An orthopedic sleep brand, established in 2020, specializes in mattresses, toppers, and pillows designed for spinal decompression and musculoskeletal relief. The company's products are backed by certifications from renowned European institutes, which have helped build a strong domestic presence. This brand operates with a lean structure, outsourcing functions such as advertising, logistics, e-commerce, and creative production to external specialists, allowing it to remain efficient and scalable with just two internal employees. Its low fixed costs and agile operations make it well-prepared for international expansion. Partnerships with manufacturing suppliers enable the company to scale efficiently across European markets, reducing production costs substantially. While these suppliers have only recently become operational, the cost benefits are already evident in the company's financials. The brand has prepared itself for global expansion, presenting a significant growth opportunity for potential buyers. In 2024, the company achieved about €4M in revenue with strong profit margins. However, in 2025, there was a slight downturn during off-peak months due to transitioning to a new supplier, needing regular updates to advertising content, and optimizing the website for better conversions. These challenges are seen as opportunities for growth for a buyer with the resources to address them effectively. The decision to sell stems from the founder's desire to pursue a new venture, rather than any business issues. With its solid biomedical brand positioning, efficient and scalable operations, and untapped international potential, the company offers an attractive acquisition opportunity in the health and sleep industry.